PrEP for Black Americans: The HIV Prevention Pill Few of Us Get

PrEP stands for pre-exposure prophylaxis. It is HIV medicine you take before any exposure, so the virus cannot take hold if it reaches your body. The CDC reports PrEP reduces the risk of getting HIV from sex by about 99 percent when used as prescribed, and by at least 74 percent from injection drug use. It is one of the most effective prevention tools in medicine. The problem is not whether it works. The problem is who gets offered it.

Black Americans are about 12 percent of the US population and accounted for 38 percent of new HIV diagnoses in 2022, the CDC reports. The diagnosis rate for Black people is more than eight times the rate for White people. PrEP could close much of that gap. Instead, Black communities use it least.

The PrEP-to-need ratio measures how well prescriptions reach the people who would benefit. A high number means good coverage. AIDSVu's 2024 data put the White ratio at 41.7 and the Black ratio at 5.8, a more than sevenfold difference. The medicine is the same. The access is not.

PrEP is a small set of options, and you do not have to pick the hardest one. Here is the full menu the CDC and HIV.gov describe:

Daily pills. Truvada (emtricitabine/tenofovir disoproxil fumarate, also sold as a generic) and Descovy (emtricitabine/tenofovir alafenamide) are once-a-day tablets. Truvada is approved for anyone at risk; Descovy is approved for everyone except people assigned female at birth who have receptive vaginal sex, because it was not studied in that group.

On-demand 2-1-1 dosing. For some gay and bisexual men who can plan ahead, Truvada can be taken around specific sex events: two pills 2 to 24 hours before, one pill 24 hours later, and one pill 48 hours after the first dose. The CDC notes this off-label schedule has strong evidence for anal sex with Truvada only; it has not been validated for Descovy or for vaginal sex.

The shot every 2 months. Cabotegravir (Apretude) is a long-acting injection a provider gives every other month. The CDC reports it is more than 99 percent effective for sex and removes the need to remember a daily pill.

The twice-a-year shot. In June 2025 the FDA approved injectable lenacapavir (Yeztugo), given every six months. In its two trials, lenacapavir prevented HIV in 100 percent of female participants and 96 percent of a mostly male trial population, and the CDC issued clinical guidance for its use the same year. Two shots a year is now a real option.

PrEP is for anyone who is HIV negative and wants protection. The single most important rule the CDC gives clinicians: if a patient asks for PrEP, that request alone is reason to offer it. You do not have to justify your sex life to qualify.

The CDC also flags specific situations across all genders and orientations: having a partner living with HIV, especially one whose virus is not suppressed; anal or vaginal sex in the past six months with a partner whose status you do not know; a recent bacterial STI; or sharing injection equipment. PrEP is not a gay men's drug. Black women are diagnosed with HIV at far higher rates than other women, and PrEP is for them too. So is it for trans people, who are often the least likely to be offered it.

The barriers are practical and they stack. Cost and insurance gaps come first: PrEP requires lab visits and follow-ups, and an uninsured person can face real out-of-pocket charges. Many Black patients are simply never offered PrEP, because clinician bias and assumptions about who is at risk leave it out of the conversation. Medical mistrust, earned through generations of mistreatment, makes some people wary of a daily drug from a system that has not earned their trust. Stigma does the rest, since asking about PrEP can feel like an admission rather than a smart, ordinary health decision.

None of these is your failure. They are reasons to walk in already knowing what to ask for. If your current provider does not bring it up, you can. If they brush you off, that is a signal to find a clinician who takes Black patients seriously. You can find a Black or affirming clinician in our directory who will start the conversation with you.

Getting started takes one visit and a few steps. You need a negative HIV test first, because PrEP is for people who do not have HIV, plus basic labs to check kidney function and screen for other STIs. After that you get a prescription, then a check-in roughly every three months to retest and refill. If a clinic visit is hard to reach, telehealth PrEP services can do the intake, order labs at a local draw site, and mail the medication.

If cost is the barrier, the federal Ready, Set, PrEP program provides the medication free to people who are uninsured, have a negative HIV test, and have a prescription. Manufacturer assistance programs and HRSA-funded community health centers can cover or reduce the cost of visits and labs as well. To start, ask any clinician for a PrEP visit, or find a Black-serving clinician who will run the test, order the labs, and connect you to a program that fits your coverage. If a provider has dismissed your concerns before, our piece on why finding a Black doctor matters covers how concordant care changes what gets offered.